triptolide has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Huang, Y; Lei, T; Li, R; Sun, W; Wang, J; Xie, R; Zhang, Z | 1 |
| Chen, J; Lei, T; Li, R; Shu, K; Sun, W; Wang, J; Zhang, H; Zhang, Z | 1 |
2 other study(ies) available for triptolide and Pituitary Neoplasms
| Article | Year |
|---|---|
Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clone Cells; Corticotrophs; Diterpenes; Epoxy Compounds; Female; Hormones; MAP Kinase Signaling System; Mice; Mice, Nude; Mitochondria; NF-kappa B; Phenanthrenes; Pituitary Neoplasms; Pro-Opiomelanocortin; Signal Transduction; Transcription, Genetic | 2017 |
Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Topics: ADAM12 Protein; Adenoma; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Movement; Cell Survival; Diterpenes; Epoxy Compounds; ErbB Receptors; Mice; Phenanthrenes; Pituitary Gland; Pituitary Neoplasms; Signal Transduction | 2018 |